Clinical studies of photodynamic therapy for roentgenographically occult lung cancer

Lung Cancer ◽  
1994 ◽  
Vol 11 ◽  
pp. 143
Author(s):  
H. Kato ◽  
K. Furuse ◽  
M. Fukuoka ◽  
T. Horai ◽  
H. Wada ◽  
...  
1995 ◽  
Vol 16 (Supplement) ◽  
pp. 511-512
Author(s):  
Yoji Ishii ◽  
Michimaro Ejiri ◽  
Takuro Tsukube ◽  
Kiyoko Hirano ◽  
Sumio Nishi ◽  
...  

CHEST Journal ◽  
2020 ◽  
Vol 157 (6) ◽  
pp. A239
Author(s):  
S. Bansal ◽  
R. Bechara ◽  
J. Patel ◽  
H. Mehta ◽  
J. Ferguson ◽  
...  

Photonics ◽  
2021 ◽  
Vol 8 (8) ◽  
pp. 303
Author(s):  
Gerhard Litscher ◽  
Laura Marinela Ailioaie

Up to now it has not yet been scientifically proven whether the technical methods of photonics in the field of photobiomodulation (PBM), photodynamic therapy (PDT), and laser acupuncture in connection with COVID-19 have achieved effective medical success. As part of this short technical note, an overview of the current scientific status is given and new equipment from our own research area is briefly presented. Although there are still many unanswered questions, it seems to be emerging that PBM and PDT in connection with the corresponding photosensitizers may make it appear worthwhile to perform experimental and clinical studies, primarily as so-called home therapy studies. In any case, the technical requirements for this are already in progress.


2013 ◽  
Vol 10 (4) ◽  
pp. 672-676 ◽  
Author(s):  
Xiao-jun Cai ◽  
Wen-min Li ◽  
Lan-ying Zhang ◽  
Xian-wei Wang ◽  
Rong-cheng Luo ◽  
...  

1996 ◽  
Vol 2 (4) ◽  
pp. 203-206 ◽  
Author(s):  
Tetsuya Okunaka ◽  
Harubumi Kato ◽  
Chimori Konaka ◽  
Kinya Furukawa ◽  
Masahiko Harada ◽  
...  

Photodynamic therapy (PDT) utilizing Photofrin is proving to be effective for the treatment of early stage lung cancer. However, wider clinical applications of Photofrin as a photosensitizer for various cancers are hampered by potentially serious and prolonged skin photosensitivity. To prevent these side effects and reduce the hospitalization period, we recently gave reduced doses of Photofrin by bronchial arterial infusion. Five patients with endoscopically evaluated minimally invasive carcinoma of the lung were given 0.7 mg/kg of Photofrin by bronchial arterial infusion 48 hr before PDT. Complete remission was obtained in all 5 cases and no case showed skin photosensitivity when exposed to sunlight under careful surveillance at one week after PDT.


2007 ◽  
Vol 62 (3) ◽  
pp. 175 ◽  
Author(s):  
Ju Ock Kim ◽  
Mi Kyoung Jung ◽  
Sung Soo Jung

Sign in / Sign up

Export Citation Format

Share Document